Trials / Unknown
UnknownNCT04372381
Supra-Annular vs. Annular ValvEs for Small Annuli
Supra-Annular vs. Annular ValvEs for Small Annuli (<= 23mm)
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Marvin Eng · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Open-label, prospective randomized comparison of Supra-annular valves (Medtronic Evolut Pro) vs. annular valves (Edwards Sapien Ultra) for small annuli (≤23 mm)
Detailed description
Patient prothesis mis-match (PPM) remains a clinical dilemma in transcatheter aortic valve replacement (TAVR) and has been linked to higher rates of morbidity and mortality. Supra-annular self-expanding valves have been linked to lower gradients and lower rates of patient prosthesis mismatch versus annular valves but they have not been directly compared. Patients with small annuli are particularly vulnerable to PPM, therefore, the aprior hypothesis is that implantation of supra-annular valves for small annuli may show differences in PPM rates and outcomes when compared to annular valves.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Transcatheter aortic valve replacement (Edwards Sapien Ultra or Medtronic Evolut Pro | Treatment of aortic valve stenosis using transcatheter aortic valve replacement |
Timeline
- Start date
- 2020-05-12
- Primary completion
- 2024-11-01
- Completion
- 2025-06-01
- First posted
- 2020-05-04
- Last updated
- 2023-01-27
Locations
3 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04372381. Inclusion in this directory is not an endorsement.